ES528120A0 - Un metodo de produccion de una preparacion de plasma activada con zymosan - Google Patents

Un metodo de produccion de una preparacion de plasma activada con zymosan

Info

Publication number
ES528120A0
ES528120A0 ES528120A ES528120A ES528120A0 ES 528120 A0 ES528120 A0 ES 528120A0 ES 528120 A ES528120 A ES 528120A ES 528120 A ES528120 A ES 528120A ES 528120 A0 ES528120 A0 ES 528120A0
Authority
ES
Spain
Prior art keywords
production method
plasma preparation
activated plasma
zymosan activated
zymosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528120A
Other languages
English (en)
Other versions
ES8503950A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of ES528120A0 publication Critical patent/ES528120A0/es
Publication of ES8503950A1 publication Critical patent/ES8503950A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES528120A 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan Expired ES8503950A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
ES528120A0 true ES528120A0 (es) 1985-04-16
ES8503950A1 ES8503950A1 (es) 1985-04-16

Family

ID=27003359

Family Applications (5)

Application Number Title Priority Date Filing Date
ES521279A Expired ES8405621A1 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528118A Granted ES528118A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral
ES528121A Expired ES8601703A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg
ES528120A Expired ES8503950A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES521279A Expired ES8405621A1 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528118A Granted ES528118A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral
ES528121A Expired ES8601703A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Country Status (13)

Country Link
EP (1) EP0091784B1 (es)
AU (2) AU569467B2 (es)
CA (1) CA1230555A (es)
DE (1) DE3374756D1 (es)
DK (1) DK154283A (es)
ES (5) ES8405621A1 (es)
FI (1) FI831169L (es)
GB (2) GB2119803B (es)
GR (1) GR78514B (es)
NO (5) NO831223L (es)
PT (1) PT76505B (es)
RO (3) RO89498A (es)
ZW (1) ZW7583A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
AU6498494A (en) * 1993-04-08 1994-11-08 Board Of Regents, The University Of Texas System Model for gonococcal infection
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
CA2761907A1 (en) * 2009-05-14 2010-11-18 Oatmeal Biotechnologies Group, L.L.C. Platform technologies for spontaneously occurring diseases
ES2900302T3 (es) * 2016-04-28 2022-03-16 Alkahest Inc Fracciones de plasma como terapia para el crecimiento y la progresión del tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
SE7904276L (sv) * 1978-05-17 1979-11-18 Benzon As Alfred Renat cancerassocierat protein

Also Published As

Publication number Publication date
ES521279A0 (es) 1984-06-16
DK154283D0 (da) 1983-04-07
ES528121A0 (es) 1985-11-01
DK154283A (da) 1983-10-08
PT76505A (en) 1983-05-01
NO841498L (no) 1983-10-10
ES528119A0 (es) 1985-04-16
ZW7583A1 (en) 1983-06-29
FI831169L (fi) 1983-10-08
RO86661B (ro) 1985-03-01
AU1286583A (en) 1983-10-13
NO831223L (no) 1983-10-10
GB2163164B (en) 1986-09-03
NO841496L (no) 1983-10-10
AU1560088A (en) 1988-10-27
RO89496A (ro) 1986-06-30
ES8503954A1 (es) 1985-04-16
EP0091784A3 (en) 1984-07-11
AU569467B2 (en) 1988-02-04
NO841497L (no) 1983-10-10
CA1230555A (en) 1987-12-22
GB8309348D0 (en) 1983-05-11
RO89498A (ro) 1986-06-30
GR78514B (es) 1984-09-27
ES8503953A1 (es) 1985-04-16
EP0091784B1 (en) 1987-12-02
NO841495L (no) 1983-10-10
GB2163164A (en) 1986-02-19
ES8503950A1 (es) 1985-04-16
FI831169A0 (fi) 1983-04-06
GB8510892D0 (en) 1985-06-05
DE3374756D1 (en) 1988-01-14
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
PT76505B (en) 1986-05-05
RO86661A (ro) 1986-07-30
EP0091784A2 (en) 1983-10-19
ES528118A0 (es) 1985-04-16
GB2119803A (en) 1983-11-23
ES8405621A1 (es) 1984-06-16

Similar Documents

Publication Publication Date Title
ES535745A0 (es) Un metodo de producir una vacuna para la hepatitis
ES519533A0 (es) Un metodo de producir una solucion de insulina.
ES547578A0 (es) Un metodo de produccion de una solucion inyectable de un antraciclina glicosido
ES528620A0 (es) Un metodo de preparacion de una espuma de poliorganosiloxano.
ES542028A0 (es) Un metodo de producir una composicion de interleuquina-2
AR229612A1 (es) Metodo de licuar una carga de vidrio
ES497559A0 (es) Metodo de fabricacion de una lampara de descarga
ES528856A0 (es) Un metodo de construir una cubierta de neumatico
YU123083A (en) Method of manufacturing circular concrete constructions
ES526247A0 (es) Un metodo de produccion de una preparacion de enzima inmovilizado
ES519771A0 (es) Un metodo de producir una preparacion farmaceutica que contiene un derivado de sulfonil urea.
ES506113A0 (es) Un metodo de fabricar una espuma fenolica
IT1140141B (it) Processo per la preparazione di una miscela di iorocarburi
RO89344A (ro) Procedeu de preparare a alcoolilor
ES504018A0 (es) Un metodo de fabricar una disposicion de interconexion elec-trica
IT1153991B (it) Metodo per creare una struttura a metallizzazione dielettrico
ES528120A0 (es) Un metodo de produccion de una preparacion de plasma activada con zymosan
ES496884A0 (es) Metodo de fabricacion de una lampara de descarga
ES540907A0 (es) Un metodo de producir una composicion farmaceutica estabili-zada
IT1163512B (it) Procedimento di produzione di una miscela carbone-liquido pompabile
IL63433A0 (en) A method of asymmetrical epoxidation
ES530184A0 (es) Metodo de producir una preparacion yodofora farmaceutica
ES525656A0 (es) Un metodo de preparar profarmacos de pilocarpina
RO90519A (ro) Procedeu de preparare a clorotioformiatilor
ES503801A0 (es) Un metodo de fabricacion de una pelicula orientada biaxial- mente